Allakos Investigational Site

Iowa City, Iowa 52242

0 studies enrolling now · 2 studies all time

What they study most

Eosinophilic Duodenitis, Eosinophilic Esophagitis, Eosinophilic Gastritis

Studies at this site

• A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis — Completed
• A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis — Withdrawn before enrolling